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Background: Type 2 diabetes is associated with obesity, ectopic lipid accumulation and low-grade inflammation. A
dysfunctional gut microbiota has been suggested to participate in the pathogenesis of the disease. Green tea is
rich in polyphenols and has previously been shown to exert beneficial metabolic effects. Lactobacillus plantarum
has the ability to metabolize phenolic acids. The health promoting effect of whole green tea powder as a prebiotic
compound has not been thoroughly investigated previously.
Methods: C57BL/6J mice were fed a high-fat diet with or without a supplement of 4% green tea powder (GT), and
offered drinking water supplemented with Lactobacillus plantarum DSM 15313 (Lp) or the combination of both
(Lp + GT) for 22 weeks. Parameters related to obesity, glucose tolerance, lipid metabolism, hepatic steatosis and
inflammation were examined. Small intestinal tissue and caecal content were collected for bacterial analysis.
Results: Mice in the Lp + GT group had significantly more Lactobacillus and higher diversity of bacteria in the
intestine compared to both mice in the control and the GT group. Green tea strongly reduced the body fat
content and hepatic triacylglycerol and cholesterol accumulation. The reduction was negatively correlated to the
amount of Akkermansia and/or the total amount of bacteria in the small intestine. Markers of inflammation were
reduced in the Lp + GT group compared to control. PLS analysis of correlations between the microbiota and the
metabolic variables of the individual mice showed that relatively few components of the microbiota had high
impact on the correlation model.
Conclusions: Green tea powder in combination with a single strain of Lactobacillus plantarum was able to promote
growth of Lactobacillus in the intestine and to attenuate high fat diet-induced inflammation. In addition, a
component of the microbiota, Akkermansia, correlated negatively with several metabolic parameters known to be
risk factors for the development of type 2 diabetes.
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The prevalence of obesity and associated type 2 diabetes
is increasing rapidly and is a worldwide health problem
[1]. The mechanisms whereby obesity leads to insulin re-
sistance and type 2 diabetes involve ectopic lipid accu-
mulation and low-grade inflammation. Non-alcoholic
fatty liver disease is strongly associated with both obesity
and type 2 diabetes [2]. Also, the pathogenesis of obesity
and type 2 diabetes has been associated with a dysfunc-
tional gut microbiota [3,4]. The mammalian gut is colo-
nised with a diverse range of microorganisms that are
known to play an important role in host metabolism
[3,5,6]. Manipulation of the microbiota in mice using
prebiotics [7] or antibiotics [8,9] has been shown to have
beneficial effects on adiposity, glucose tolerance and in-
flammation. Also, addition of a probiotic mixture of
strains has been shown to improve high-fat diet-induced
hepatic steatosis, inflammation and insulin sensitivity in
rodents [10,11]. Thus, the composition of the gut micro-
biota seems to play an important role in the regulation
of lipid and glucose metabolism, as well as in inflamma-
tory pathways.
Most studies on the microbiota in animals and
humans have focused on caecum (rodents), colon
(humans) or faeces as a reflection of the caecal or co-
lonic microbiota. However, the small intestine appears to
play an important role in the development of obesity
and type 2 diabetes, as illustrated by the outcome of bar-
iatric surgery where by-passing parts of the upper
human gastrointestinal tract promotes weight-loss,
ameliorate type 2 diabetes and improves hyperlipidemia
[12].
Green tea is suggested to possess health promoting
properties. It is a rich source of polyphenols, especially
catechins, which represent approximately 30% of fresh
leaf dry weight [13]. Extract from green tea or tea cate-
chins have previously been shown to have anti-obesity
and anti-diabetic effects in animal models [14-19] as well
as in humans [20-22]. Most studies regarding health
effects of green tea have been performed on tea extract
or catechin fractions. Few studies have dealt with the
effects of powdered whole green tea leafs, which include
both water- and non-water soluble polyphenols as well
as dietary fibres. Green tea powder is increasingly
included as a supplementary ingredient in foods, e.g. in
bakeries and desserts. Green tea catechins are poorly
absorbed in the intestine and are thus present in the in-
testinal lumen where they are suggested to inhibit lipid
absorption by forming complexes with lipids and lipo-
lytic enzymes [23].
The species Lactobacillus plantarum (L. plantarum)
has the ability to metabolize phenolic acids [24] and to
split up tannins [25,26]. The metabolites are presumably
more easily absorbed and distributed into the tissueswhere they can act as antioxidants and electron scaven-
gers. Phenolic compounds can also have antimicrobial
effects that may affect the composition of the gut micro-
biota, in favour of polyphenol-metabolizing components
of the microbiota [27]. Also, green tea extracts have
been shown to selectively inhibit the growth of patho-
genic bacteria while either enhancing or not affecting
the growth of beneficial bacteria like lactic acid bacteria
[28-30]. To the best of our knowledge, the impact of
green tea powder as a prebiotic compound to promote
lactobacilli or other health promoting components of
the microbiota has not previously been evaluated.
We report here a comprehensive study on the effects
of green tea powder, with or without the addition of L.
plantarum DSM 15313, on metabolic parameters and on
the microbiota in both the small intestine and in the
caecum of high-fat fed C57BL/6J mice. Our results dem-
onstrate that the combination of green tea powder and
L. plantarum alter the intestinal microbiota, reduce in-
flammation and affect cholesterol metabolism in a
mouse model for human obesity and insulin resistance.
Methods
Animals and study design
The study followed the European Community regula-
tions for animal experiments and was approved by the
local animal ethics committee, Lund, Sweden, (permis-
sion number M202-08). Eight-week old female C57BL/
6JBomTac mice, weighing 18.2 ± 2.2 g (Taconic,
Skensved, Denmark) were housed 7 mice/cage in a con-
trolled environment (12 hour light cycle). After one
week of acclimatization, the mice were randomly divided
into four groups (n = 21), and thereafter fed the experi-
mental diets ad libitum with free access to drinking
water. The two experimental diets were high-fat diets
(HFD, 45 energy% fat; Research Diets, NB, USA), with
(D08021404) or without (D12451N) supplement of 4%
(w/w) powdered green tea leaves (Camellia sinensis, Pre-
mium Powdered Sencha, www.JapaneseGreenTeaOnline.
com). The green tea powder was analyzed for nutritional
content including water soluble and insoluble fibers
(Eurofins, Lidköping, Sweden) as well as water soluble
and insoluble polyphenols, see Additional files 1 and 2,
respectively. The drinking water was supplemented with
1.5% (v/v) of either freezing medium (3.6 mM K2HPO4,
1.3 mM KH2PO4, 2.0 mM sodium citrate, 1.0 mM
MgSO4, 12% glycerol) or L. plantarum DSM 15313
(strain HEAL19, Probi AB, Lund, Sweden) suspended in
freezing medium to a concentration of 3 × 109 cfu/ml
drinking water, giving an approximate intake of 1 ×
1010 cfu/day. The concentrated aliquots of bacteria sus-
pension were stored in −20°C and mixed with fresh tap
water on a daily basis. L. plantarum has previously been
shown to be stable during 24 hours in tap water at room
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body weights were registered once a week. After 5, 11
and 22 weeks, body fat mass was analyzed using dual-
energy X-ray absorptiometry technique with a Lunar
PIXImus densitometer (GE Medical Systems). Oral glu-
cose tolerance tests were performed after 8 and 21 weeks
and an intravenous insulin tolerance test was performed
after 15 weeks. Two mice in the Lp group did not wake
up from the anaesthesia after the first oral glucose toler-
ance test. Faeces were collected at three different time
points during the study. Mice were placed in clean cages
with a minimum of bedding for 24 hours. Faeces from
each cage was collected, lyophilized and grounded in a
mortar and stored at −20°C until analysis. After
11 weeks, 10 mice in each group were sacrificed in order
to study time dependency of the treatment, and after
22 weeks, the remaining mice (9–11 per group) were
sacrificed. At the time of sacrifice, mice were fasted for
4 hours and thereafter anesthetized with an intraperito-
neal injection of midazolam (Dormicum, Hoffman- La
Roche, Basel, Switzerland) and a mixture of fluanison/
fentanyl (Hypnorm, Janssen, Beerse, Belgium). Blood
was drawn by intraorbital puncture followed by cervical
dislocation. Periovarian white adipose tissue, liver (rinsed
with PBS) and spleen were weighed and snap-frozen in
liquid nitrogen. A part of the duodenum (3–10 mm
distally of pylorus) was collected in buffer containing
10 mM Tris-HCl and 1 mM EDTA, pH 8.0, and snap-
frozen in liquid nitrogen. The caecum including its
content was weighed and thereafter the wall was
removed. Parts of the content were frozen in freezing
medium for culture of bacteria and parts were snap
frozen for extraction of bacterial DNA. All samples were
stored at −80°C until analysis.Viable count
Plate count was performed on the caecum content and
the samples were cultivated on Violet Red Bile Dextrose
agar (Enterobacteriaceae) incubated aerobically at 37°C
for 24 hours and on Rogosa agar (lactobacilli) incubated
anaerobically at 37°C for 48 hours. From Rogosa plates,
1–2 colonies morphologically resembling L. plantarum
were picked for tentative identification of L. plantarum
DSM 15313 by Random Amplified Polymorphic DNA
(RAPD) analysis (for details regarding RAPD see Additional
file 3).DNA extraction from intestinal samples
DNA was extracted from the caecum content using a
Biorobot EZ1 and a DNA Tissue Kit (Qiagen AB, Sollen-
tuna, Sweden) as previously described [32]. Extracted
DNA was eluted in 200 μl by the Biorobot EZ1 accord-
ing to the manufacturer’s instruction.Amplification and T-RFLP analysis
The universal primers ENV1 and ENV2 were used for
amplification of the bacterial 16S rRNA genes [33]. The
forward ENV1 primer was fluorescently labelled with
FAM. The amplicons were then purified and digested
with the restriction endonuclease MspI. For caecum
samples the restriction endonuclease AluI (Fermenta
Life Science) was also used (for details see Additional file
3). Samples were analyzed at DNA-lab (SUS, Malmö,
Sweden). The total area was summarized for each sam-
ple and the relative area for each T-RF was calculated
and expressed as a percentage of the total area. In order
to identify peaks in the T-RFLP profile a pure culture of
L. plantarum DSM 15313 and a selected clone obtained
previously from mouse caecum content that had been
identified by partial sequencing of the 16S rRNA genes
as Akkermansia (unpublished results) were digested by
MspI and analyzed by T-RFLP.
Cloning and sequencing of the 16S rRNA genes
The bacterial 16S rRNA genes of the small intestinal
samples were amplified with the primers ENV1 and
ENV2. The cloning was performed using the pGEM-T
vector system II (Promega, Madison, USA) as previously
described [33]. Randomly selected clones were harvested
and stored in freezing media at −80°C (for details
regarding cloning see Additional file 3). Clones were
sent to MWG-Biotech (MWG-Biotech, Ebersberg,
Germany) for sequencing using the primer Univ-
0519-a-A-18 GWA TTA CCG CGG CKG CTG [34].
Approximately the first 450 bases were sequenced and
the obtained sequences of 16S rRNA genes were
checked and edited manually using Bioedit Sequence
Alignment Editor Version 7.0.9.0 [35]. The sequences
were compared with the Ribosomal Database Project,
release 10 using the option “Sequence Match” (Riboso-
mal Database Project, http://rdp.cme.msu.edu/) [36].
Clone sequences were also compared by using the op-
tion “similarity table”, found at http://mobyle.pasteur.
fr/cgi-bin/portal.py#forms::dnadist. Ten clones were
selected, one from each operational taxonomic unit
containing sequences showing >98% similarity, and
submitted to GenBank. The accession numbers are
JX971027-JX971036. Sequences are named with the
acronym Msi (mice small intestine).
SYBR Green quantitative PCR of bacteria in small intestine
Quantitative PCR (qPCR) was run separately in a Master-
cyclerW ep realplex 1.5 real-time PCR system (Eppendorf)
using primers for Lactobacillus, Akkermansia, Entero-
bacteriaceae and total bacteria (for primer sequences
and details see Additional files 3 and 4). The stan-
dards for qPCR were prepared by cloning the target
fragments of the 16S rRNA genes from L. plantarum
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tion, University of Gothenburg, Sweden). The former
was used as template for Lactobacillus and total bac-
teria and the latter for Enterobacteriaceae. For Akker-
mansia a previously obtained clone from mouse
caecum was used for the preparation of a standard (for
details see Additional file 3).
Diversity index
For comparison of the microbial diversity between the
groups both the Shannon and Simpson’s diversity indices
were calculated [37,38]. Both indices take evenness and
species richness into account but the Simpson index is
more weighted towards the abundance of the most com-
mon species than species richness [38]. The area of each
T-RF, expressed as the proportion of the total area for a
sample, was used for calculation.
Lipid extraction from faeces and liver
Lipids in faeces were extracted with hexane:isopropanol
(3:2) and dried under nitrogen. The lipids were re-
dissolved in isopropanol. Whole liver was grounded to a
homogenous powder in a mortar in liquid nitrogen. An
aliquot of the powdered liver was homogenized in phos-
phate buffered saline and thereafter lipids were extracted
with chloroform:methanol (2:1) overnight. The organic
phase was washed, dried under nitrogen and re-
suspended in chloroform. Triacylglycerol (TAG) and
cholesterol were analyzed (Infinity, Thermo Electron
Melbourne, Australia).
RNA preparation from liver tissue and real-time qPCR
Total RNA was isolated from grounded liver (see above)
using the RNeasy Mini Plus Kit (Qiagen, Hilden,
Germany) according to the manufacturer’s instruc-
tion. Total RNA (1 μg) was treated with DNaseI
amplification grade (Invitrogen, Carlsbad, CA, USA)
and reversely transcribed using random hexamers
(Amersham Bioscieces, Piscataway, NJ, USA) and Super-
Script II RNaseH reverse transcriptase (Invitrogen) accord-
ing to the manufacturer’s recommendations. The
cDNA was used for quantitative PCR using TaqMan
chemistry (assays-on-demand, Applied Biosystems) or
SYBR green chemistry (primers were designed using
the software Primer Express, Applied Biosystems),
with an ABI 7900 system (Applied Biosystem, Foster
City, CA, USA), see Additional file 5 for assay IDs of
the Taqman probes and list of primer sequences. The
relative quantification of mRNA was calculated using
the ΔΔCt-method with normalization by geometric
average of the two housekeeping genes ribosomal
protein S29 (RPS29) and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) [39].Oral glucose tolerance test
Mice fasted for 10 hours (9 p.m.–7 a.m.) were anesthe-
tized with 0.4–0.6 mg Fluanison, 0.01–0.02 mg Fentanyl
(Hypnorm) and 0.2–0.3 mg Midazolam (Dormicum) per
mouse. D-glucose (75 mg in 0.5 ml) was given by intra-
gastric gavage. Blood samples were drawn by intraorbital
puncture using an EDTA-coated glass pipette at 0, 15,
30, 60 and 120 min after glucose administration. After
immediate centrifugation plasma was collected and
stored at −20°C until analysis of glucose and insulin.
Insulin tolerance test
Mice fasted for 4 hours (9 a.m.–1 p.m.) were anesthe-
tized as above. Insulin (ActrapidW, Novo Nordisk A/S,
Denmark) was injected intraperitoneally (0.75 mU/g
body weight). Blood samples were drawn as above at 0,
15, 30, 45, 60 and 90 minutes after insulin administra-
tion for glucose analysis.
HOMA index
Insulin resistance was assessed by the homeostasis
model assessment (HOMA), a mathematical model de-
scribing the degree of insulin resistance from fasting gly-
caemia and insulineamia. HOMA-IR is calculated by
multiplying fasting plasma insulin (mU/l) with fasting
plasma glucose (mmol/l) divided by 22.5 [40].
Plasma samples
At week 11 and 22 blood was drawn from 4 hour fasted
anesthetized mice by intraorbital puncture. Plasma was
prepared and stored as above. Glucose, cholesterol, TAG
(Infinity, Thermo Electron Melbourne, Australia), non-
esterified fatty acids (NEFA) (NEFA C, Wako Chemicals,
Neuss, Germany), fructosamine (VetSpecTM, Catachem
Inc., Oxford, CT, USA) and alanine aminotransferase
(ALT) (DiscretePakTM, Catachem Inc.) were measured
enzymatically. Insulin and adiponectin were measured
radioimmunochemically (Linco Research, St Charles,
MO, USA). Leptin, interleukin-6 (IL-6), monocyte
chemoattractant protein −1 (MCP-1) and plasminogen
activator inhibitor-1 (PAI-1) were analyzed in an aliquot
of plasma that had been snap-frozen in liquid nitrogen
and stored at −80°C using Luminex technology (LX200,
Luminex Corporation, Austin, TX, USA). Before the
onset of the study 10 mice were sacrificed and blood
was collected to measure baseline glucose and insulin.
Statistics
For the bacterial analyses, multiple groups’ comparisons
were performed using Kruskal-Wallis test, pair-wise
comparisons using Nemenyi-Damico-Wolfe-Dunn test
(NDWD), and correlations using Spearman’s rank cor-
relation test with Bonferroni correction for multiple test-
ing. Correlation tests were carried out between the total






















Figure 1 Quantification (PCR-copies) of Lactobacillus in small
intestinal tissue after 22 weeks. Significant differences were
reached for Lactobacillus between the control group and the Lp +
GT group (p = 0.002), and between the groups receiving GT and Lp +
GT (p = 0.04). Ctrl = high fat control diet (HFD), Lp = HFD + L. plantarum
in the drinking water, GT = HFD supplemented with 4% green tea
powder, Lp + GT = HFD supplemented with 4% green tea powder and
L. plantarum in the drinking water.
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Lactobacillus and Akkermansia as well as small intestinal
and caecal diversity, and body weight, total body fat con-
tent, periovarian white adipose tissue, plasma leptin,
plasma fructosamine, basal plasma glucose and insulin,
the area under the curve for the oral glucose tolerance
tests, liver weight, hepatic TAG content, plasma ALT,
plasma TAG, plasma NEFA, plasma adiponectin, plasma
PAI-1, spleen weight and caecum weight. The statistical
tests were performed using the stat package [41,42] and
the add-on package “coin” [43,44] in the statistical soft-
ware R (version 2.10.1, R Development Core Team,
2009).
For the rest of the data, one-way analysis of vari-
ance (ANOVA) with Bonferroni’s multiple compari-
son post-test was used when the data was Gaussian
distributed according to D’Agostino and Pearson omni-
bus normality test. When not normally distributed,
Kruskal-Wallis non-parametric test with Dunn’s mul-
tiple comparison post-test was used. Also, two-way
ANOVA with Bonferroni post-test was used to com-
pare body weights. The statistical analyses were per-
formed with the GraphPad Software (GraphPad Prism
5.0, San Diego, CA, USA). All tests were two-sided and
data were considered significant if P < 0.05.
Multivariate data analysis
Principal component analysis (PCA) was applied to the
T-RFLP data (a matrix of the relative peak area) and to
the metabolic data in order to clarify cluster-structures
in the data sets (SIMCA-P software, version 12.0.1;
Umetrics, Umeå, Sweden). The two sets of data were
used to build a Partial Least Squares Projections to La-
tent Structures (PLS) model in order to find correlations
between them (Autofit in the SIMCA-P). First, all the
metabolic parameters were used to build the PLS model,
thereafter, those with Q2 < 0.2, which indicates a weak
correlation against the small intestinal or caecal T-RFLP
pattern, were excluded from the model.
Results
Microbiota of the small intestine
The microbiota of the small intestine was analyzed by
qPCR and T-RFLP at 22 weeks. Two samples were also
subjected to cloning and sequencing of the 16S rRNA
genes. The PCR-quantified load of Lactobacillus differed
between the groups after 22 weeks (p = 0.002). Pair wise
comparison showed that the Lp + GT group had signifi-
cantly more Lactobacillus than the control group (p =
0.002) and the GT group (p = 0.04) (Figure 1). No differ-
ences in the amount of the Gram-negative and mucin
degrading genus Akkermansia (belonging to the phylum
Verrucomicrobia) or total amount of bacteria were
observed between the groups. The mean values of logcopies/g for Akkermansia were 6.75 ± 0.27 (control),
6.85 ± 0.75 (Lp), 6.97 ± 0.52 (GT) and 7.09 ± 0.43 (Lp +
GT). For the total bacteria the mean values of bacterial
copies were 8.66 ± 0.38 (control), 8.81 ± 0.53 (Lp), 9.02 ±
0.40 (GT), and 9.09 ± 0.38 (Lp + GT) log copies/g. No
Enterobacteriaceae could be detected, except for in one
individual (data not shown).
T-RFLP was used for analyzing the diversity of the gut
microbiota. When using restriction endonuclease MspI
the number of T-RFs varied between the animals and
there was a significant difference in diversity based on
the number of T-RFs among the four groups (p < 0.001).
The median values of the peak numbers of the groups
were 3.5, 6.0, 6.5 and 8.0 for control, Lp, GT and Lp +
GT respectively. Pair wise comparison of the groups
revealed significant differences between control and GT
(p < 0.05), and between control and Lp + GT (p < 0.001).
Shannon (H') as well as Simpsons’s diversity index (D)
showed a significant difference among the four groups
(p = 0.007 and p = 0.006 respectively). Pair-wise compari-
son showed that the Lp + GT group had a significantly
more diverse microbiota than the control group (p =
0.008) and the GT group according to the Shannon di-
versity index (p = 0.04) (Figure 2). According to the
Simpson’s diversity index the Lp group had a signifi-
cantly higher diversity than the GT group (p = 0.04)
(data not shown). A T-RF corresponding to L. plan-
tarum DSM 15313 was found in 5 individuals in the Lp
group and in 4 individuals in the Lp + GT group. In
order to identify some of the T-RFs in the T-RFLP pro-
files, the two mice with the highest number of T-RFs in
**
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Figure 2 Bacterial diversity in the small intestine after
22 weeks. The data is based on T-RFLP-profiles and Msp1 digestion.
The area of each peak, expressed as the proportion of the total area,
was used for calculation of the Shannon diversity index. Control vs.
Lp + GT (p = 0.008), GT vs. Lp + GT (p = 0.04).
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ial cloning. The obtained sequences were edited and 55
sequences were analyzed and compared to the closest
matches in the RDP database [36] (Table 1). Fiftyone out
of fiftyfive clones belonged to the phylum Firmicutes.
Within Firmicutes, sequences similar to the family Erysi-
pelotrichaceae were dominating. These sequences were
most similar to the genus Allobaculum, but theTable 1 Direct identification of 16S rRNA genes from small in
sequencing














AF292373 Olsenella uli (T)
AB042288 Propionibacterium a
aCtrl = high fat control diet (HFD), Lp + GT + HFD supplemented with 4% green tea
denote the number of clones in each mouse. bDenotes highest sequence similarity
(http://rdp.cme.msu.edu/).similarity was only 89%. In the mouse from the Lp + GT
group, 25.9% of the clones were identified as Lactobacil-
lus compared to only 3.6% from the control mouse.
Clones identified as Lactobacillus were most similar to
sequences belonging to Lactobacillus reuteri and Lacto-
bacillus intestinalis. Due to differences between the the-
oretical and the actual sizes of T-RFs of the clones no
attempt was made to identify the T-RFs except for
Akkermansia and the given L. plantarum strain which
showed fragments length of 265 and 568 bp, respect-
ively. A comparison was made between T-RFLP and the
numbers of copies in the qPCR. The mean copy value
for Akkermansia obtained in the qPCR for the T-RFs
detected in the T-RFLP was log 7.28 ± 0.52 compared to
a mean of log 6.75 ± 0.27 for copy number that was not
detected by T-RFLP. No microbial analyses of the small
intestine were performed at 11 weeks.
Caecum weight and microbiota
After 11 weeks, the caecum weights were significantly
higher in mice from the GT groups compared to mice in
the control and Lp groups (control: 0.126 ± 0.006, Lp:
0.133 ± 0.007 GT: 0.225 ± 0.015, Lp + GT: 0.229 ±
0.015 g). After 22 weeks, the difference in caecum
weights was even more pronounced (control: 0.125 ±
0.013, Lp: 0.148 ± 0.008, GT: 0.291 ± 0.027, Lp + GT:
0.332 ± 0.022 g). The caecum microbiota was analyzed
by cultivation and by T-RFLP after 11 and 22 weeks.
The viable count of lactobacilli in the caecum content
was significantly higher in the Lp group (p <0.01) thantestinal tissue by PCR-amplification, cloning and
Group (No of clones)a Similarity (%)b
(T) Ctrl (1) 95.5
alis (T) Lp + GT (3) 99.2–99.5
(T) Lp + GT (3) 95.3–95.7
Lp + GT (1) 95.1
(T) Lp + GT (1) 89.5
canis (T) Ctrl (24) Lp + GT (17) 89.1 ~ 89.4
(T) Ctrl (1) 96.1
hila (T) Ctrl (1) 99.7
sis (T) Lp + GT (1) 88.8
Lp + GT (1) 94.4
cnes (T) Ctrl (1) 100
powder and L. plantarum in the drinking water. Numbers within parentheses
to a type strain (T) found in the Ribosomal data base project Release 10
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group had significant more lactobacilli than control (p <
0.01) and the GT-group (p < 0.05) after 22 weeks (see
Additional file 6). L. plantarum DSM 15313 was found
at both 11 and 22 weeks in the two groups fed L. plan-
tarum. L. plantarum could be reisolated from 77% and
100% of the mice in the Lp + GT and Lp groups, respect-
ively (data not shown). No significant difference in the
viable count of Enterobacteriaceae was seen after
11 weeks in the three treatment groups compared to the
control. After 22 weeks, the viable count of Enterobac-
teriaceae had decreased below the detection limit in
more than 40% of the animals and no statistical analysis
was made (data not shown).
T-RFLP analysis of the caecum content generated in
total 72 different T-RFs after 11 weeks and 82 T-RFs
after 22 weeks in the T-RFLP-profile using MspI. At
11 weeks the GT group had significantly more T-RFs
than the control when using MspI (p < 0.01). For AluI
digestions, both the GT group and the Lp + GT group
had significantly more T-RFs than the control group
(p < 0.05). After 22 weeks there were no differences
compared to the control with either MspI or AluI (data
not shown). Shannon and Simpson diversity indices were
calculated for each sample using the relative T-RF area.
After 11 weeks both the Shannon and the Simpson indi-
ces showed a significantly higher diversity of the micro-
biota in the GT group compared to the control when
using Alu1 digestion for the former and either MspI or
Alu1 digestion for the later (see Additional file 7). After
22 weeks, no significant differences in the bacterial di-
versity of the caecum content could be seen between the
treatment groups and the control (see Additional file 7).
In order to perform a putative identification of T-RFs
from the caecum content, a pure culture of L. plan-
tarum DSM 15313 was analyzed by T-RFLP, showing a
single T-RF of 568 base pairs. This T-RF was not found
in the control group or in the GT group but in all ani-
mals of the Lp group and in 75% of the mice in the Lp +
GT group. Also, a T-RF (265 bp) corresponding to Akker-
mansia was found in 27 mice of 29 after 11 weeks and in
40 mice of 43 after 22 weeks.
Adiposity
Body weight gain and relative body fat content was sig-
nificantly reduced in mice of the GT groups compared
to control mice (Figure 3A, C). A supplement of Lp had
no significant effect on body weight or body fat content.
The mean energy intake was higher in mice fed GT
compared to mice fed a diet without GT (Figure 3B). In
addition, periovarian white adipose tissue depots
(Figure 3E) and circulating leptin (Figure 3F) were
strongly reduced in mice receiving GT. No significant
difference in lean body mass was observed betweengroups (Figure 3D). The amount of Akkermansia in the
small intestine correlated negatively with body fat con-
tent (rho = −0.43; p = 0.04), periovarian white adipose
tissue (rho = −0.43; p = 0.03) as well as plasma leptin
(rho = −0.45; p = 0.03). The total amount of bacteria in
the small intestine correlated negatively with periovarian
white adipose tissue (rho = −0.41; p = 0.04) and showed a
tendency towards a negative correlation with total body
fat (rho = −0.41; p = 0.07) and plasma leptin (rho = −0.35;
p = 0.09). The mean faecal TAG excretion was signifi-
cantly elevated in the GT groups compared to control
(control: 0.08 ± 0.01, Lp: 0.18 ± 0.05, GT: 0.27 ± 0.04, Lp +
GT: 0.31 ± 0.04 mg/mouse/24 h). The total amount of fae-
ces was not significantly different between the groups al-
though a tendency towards increased excretion was
observed in the GT groups compared to the control group
(ctrl: 0.27 ± 0.02, Lp: 0.30 ± 0.04, GT: 0.39 ± 0.06, Lp +GT:
0.40 ± 0.06 mg/mouse/24 h).
Blood glucose control
Oral glucose tolerance tests were performed at week 8
and week 21. At week 8, the mice in the two GT
groups had a significantly increased insulin response
compared to control mice (Figure 4B). Also, the Lp +
GT group had a significantly increased glucose re-
sponse compared to the control and the Lp group
(Figure 4A). The same tendencies were seen at week 21,
however, the differences did no longer reach statistical
significance (Additional file 8). An insulin tolerance test
was performed at week 15. No significant differences
were observed between any of the groups (Figure 4C).
After 22 weeks, fasting plasma glucose, insulin and
fructosamine were lower in the mice from the GT
groups, while insulin and fructosamine were signifi-
cantly lower already after 11 weeks (Table 2). In
addition, after 22 weeks, GT resulted in a lower HOMA
index of insulin resistance (Figure 4D). The amount of
Akkermansia in the small intestine correlated negatively
to plasma insulin (rho = −0.47; p = 0.03) and there was
also a tendency towards a negative correlation between
the total amount of bacteria and plasma insulin (rho-
0.35; p = 0.07). No differences in plasma glucose or insu-
lin were observed between the groups at the initiation of
the study (data not shown).
Lipid metabolism
Both the GT and Lp + GT groups had significantly lower
plasma TAG compared to control after 22 weeks
(Table 2). No differences in plasma TAG were observed
at the start of the study. Liver weights were significantly
lower in mice from both GT groups compared to control
mice after both 11 and 22 weeks (Figure 5A and B). The
liver weight was also significantly lower in the Lp + GT
group compared to the Lp group. Also the liver TAG












































































































Figure 3 Decreased adiposity in mice fed a diet supplemented with green tea. (A) Weekly body weight registration during the 22 week
study. (B) Average energy intake calculated as KJ/mouse/day. (C) Relative body fat content (%) recorded using DEXA scan technique at week 0, 5,
11 and 22. (D) Lean body mass measured with DEXA at 0, 5, 11 and 22 weeks. (E) Periovarian white adipose tissue weight and (F) plasma leptin
concentration after 22 weeks on the different diets. Ctrl = high fat control diet (HFD), Lp = HFD + L. plantarum in the drinking water, GT = HFD
supplemented with 4% green tea powder, Lp + GT = HFD supplemented with 4% green tea powder and L. plantarum in the drinking water. Data
are means ± SEM n = 21 at 11 weeks and n = 9–11 at 22 weeks. *p < 0.05, **p < 0.01, ***p < 0.001.
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groups fed GT and showed the same picture regarding
significance as the liver weight (Figure 5C and D). Be-
tween 11 and 22 weeks, there was a general increase in
liver TAG accumulation in all groups but the GT group.
Moreover, the liver enzyme ALT was decreased in
plasma from mice in the GT groups compared to the
mice in the control group (Figure 5E and F). However,
plasma ALT was generally higher in all groups after
22 weeks compared to 11 weeks. After 22 weeks the
mRNA expression of the lipogenic transcription factors
SREBP1c and PPARγ was significantly down-regulated
in both groups of mice fed GT (Figure 6A and B). The
mRNA expression of the lipogenic enzyme ACC was
decreased only in mice receiving GT compared to con-
trol, and the same trend was observed for the expressionof FAS mRNA (Figure 6C and D). The hepatic mRNA
expression of PPARα, PGC-1α, CD36, ACADL, LXR,
PXR, chREBP, XBP1, PEPCK, CREB and GK is shown in
the Additional file 9. A significant difference in the
mRNA expression of PPARα, which plays a role in the
control of fatty acid oxidation, was observed between
mice in the GT group compared to control mice at
22 weeks. Also, a decreased mRNA expression of CD36
and LXR, both involved in the control of lipogenesis,
was observed in mice from the Lp + GT group compared
to control, after 11 and 22 weeks respectively (Add-
itional file 9). The amount of Akkermansia correlated
negatively with the TAG content in the liver (rho =
−0.44; p = 0.03) and there was also a tendency towards a
negative correlation between the total amount of bac-
teria and liver TAG (rho-0.36; p = 0.07).
Table 2 Plasma profile after indicated time of dietary treatment
Week Ctrl Lp GT Lp + GT
Glucose (mM) 11 7.3 ± 0.4 8.2 ± 0.6 7.4 ± 0.7 7.5 ± 0.5
22 9.3 ± 0.5a# 9.5 ± 0.7a 6.0 ± 0.4b 7.1 ± 0.3b
Insulin (pM) 11 289 ± 48a 403 ± 50a 177 ± 12b 169 ± 12b
22 387 ± 72a 353 ± 58a 99 ± 6b* 100 ± 4b*
Fructosamine (μM) 11 535 ± 25a 629 ± 45a 429 ± 23b 545 ± 41b
22 606 ± 18a§ 582 ± 39a 521 ± 16b# 518 ± 21b
Cholesterol (mM) 11 4.2 ± 0.24a 4.3 ± 0.22 4.7 ± 0.22 4.8 ± 0.08b
22 5.2 ± 0.3a§ 5.0 ± 0.24a 3.9 ± 0.08b* 4.0 ± 0.18b*
TAG (mM) 11 0.41 ± 0.04a 0.42 ± 0.07 0.29 ± 0.03b 0.31 ± 0.02
22 0.48 ± 0.05a 0.40 ± 0.05a 0.30 ± 0.02b 0.32 ± 0.03b
NEFA (mM) 11 0.57 ± 0.02a 0.59 ± 0.04a 0.47 ± 0.03b 0.52 ± 0.03ab
22 0.52 ± 0.03 0.55 ± 0.05 0.47 ± 0.01 0.49 ± 0.03
Adiponectin (μg/ml) 11 18.1 ± 1.3 17.6 ± 1.0 14.7 ± 1.6 14.8 ± 1.7
22 18.4 ± 1.5ab 18.8 ± 0.9a 15.3 ± 0.7b 15.7 ± 0.8b
Values within a row not sharing the same letter indicate significant difference, p < 0.05.
§ p < 0.05, # p < 0.01, * p < 0.001 indicate significant difference between 11 and 22 weeks.
Figure 4 Altered glucose and insulin tolerance by supplementing the diet with green tea. (A) Plasma glucose and (B) insulin
concentrations in an oral glucose tolerance test performed at week 8. Mean values and SEM for 11 mice in each group. (C) Plasma glucose
expressed as % of basal after an intraperitoneal injection of insulin at week 15. Mean values and SEM for 9–11 mice in each group. No differences
were detected between any of the four groups. The areas under the curves (AUC) are shown in the insets (D) HOMA-IR index at week 22. The
index was calculated by multiplying fasting glucose (mM) and fasting insulin (μU/ml) divided by 22.5. Ctrl = high fat control diet (HFD), Lp = HFD + L.
plantarum in the drinking water, GT = HFD supplemented with 4% green tea powder, Lp + GT =HFD supplemented with 4% green tea powder and L.
plantarum in the drinking water. Data are means ± SEM for 9–11 mice/group. *p < 0.05, **p < 0.01, ***p < 0.001.
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Figure 5 Improved liver phenotype in mice fed a diet supplemented with green tea. Liver weights after 11 (A) and 22 (B) weeks on the
different diets. Triacylglycerol (TAG) content in liver after 11 (C) and 22 (D) weeks, respectively. The concentration of the liver enzyme ALT
measured in plasma after 11 (E) and 22 (F) weeks. Ctrl = high fat control diet (HFD), Lp = HFD + L. plantarum in the drinking water, GT = HFD
supplemented with 4% green tea powder, Lp + GT = HFD supplemented with 4% green tea powder and L. plantarum in the drinking water. Data
are means ± SEM for n = 21 at 11 weeks and n = 9–11 at 22 weeks. *p < 0.05, **p < 0.01, ***p < 0.001.
Figure 6 Decreased lipogenic gene expression in liver of mice fed a diet supplemented with green tea. Hepatic mRNA expression of
sterol regulatory-binding protein 1c (SREBP1c, A), peroxisome proliferator-activated receptor γ (PPARγ, B), acetyl CoA carboxylase (ACC, C) and
fatty acid synthase (FAS, D) was quantified with real-time PCR after 22 weeks of the different diets. Ctrl = high fat control diet (HFD), Lp = HFD + L.
plantarum in the drinking water, GT = HFD supplemented with 4% green tea powder, Lp + GT = HFD supplemented with 4% green tea powder
and L. plantarum in the drinking water. Data are means ± SEM. n = 9–11 at 22 weeks. *p < 0.05, **p < 0.01.
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Plasma cholesterol was significantly higher in the Lp +
GT group after 11 weeks but after 22 weeks it was sig-
nificantly lower in both GT groups compared to control
(Table 2). No differences in plasma cholesterol were
observed between the groups at the start of the study
(data not shown). The liver cholesterol content was
decreased in both groups receiving GT after 11 weeks,
but after 22 weeks it was also decreased in the Lp group
compared to control (Figure 7A and B). Liver cholesterol
decreased over time in all groups but Lp + GT, which
showed unchanged cholesterol content between 11 and
22 weeks. After 11 weeks, the key enzyme in cholesterol
synthesis, HMGCoA reductase was upregulated in the
Lp + GT group but no significant changes in the mRNA
expression of the cholesterol-regulating transcription
factor SREBP2 were observed between the groups
(Figure 7C and E). However, after 22 weeks, HMGCoA
reductase was significantly up-regulated in the Lp + GT
group compared to the other groups (Figure 7D) and
SREBP2 was upregulated compared to control and Lp
(Figure 7F). The hepatic expression of SR-B1, LDLR and
CYP7A1, genes involved in reverse cholesterol transport,
is shown in Additional file 9. SR-B1, an HDL receptor,
was significantly upregulated in mice fed GT compared
to control mice. The mRNA expression of the LDL re-
ceptor was down-regulated in mice in the GT group
compared to control mice but the significance wasFigure 7 Altered cholesterol homeostasis in mice fed a diet suppleme
content in liver after 11 (A) and 22 (B) weeks on the different diets. Hepati
C and D) and sterol regulatory-binding protein 2 (SREBP2, E and F) after 11
Lp = HFD + L. plantarum in the drinking water, GT = HFD supplemented wi
tea powder and L. plantarum in the drinking water. Data are means ± SEM.
***p < 0.001.eliminated with addition of Lp. Total cholesterol excre-
tion was increased in the GT groups compared to con-
trol (control: 0.64 ± 0.1, Lp: 0.65 ± 0.11, GT: 1.56 ± 0.11,
Lp + GT: 1.55 ± 0.18 mg/mouse/24 h). The hepatic chol-
esterol content and plasma cholesterol correlated nega-
tively with the total amount of bacteria (rho = −0.43; p =
0.04 and rho = −0.44; p = 0.04 respectively).
Markers of inflammation
Circulating PAI-1 was significantly decreased in mice in
the Lp + GT group compared to mice in the Lp group
(p < 0.05) after 22 weeks but not after 11 weeks
(Figure 8A and B). Plasma PAI-1 was also negatively cor-
related with Akkermansia (rho = −0.49; p = 0.03) at
22 weeks. The cytokines IL-6 and MCP-1 were analyzed
in the same multiplex assay as PAI-1, but the plasma
concentrations were below the detection limit. The hepatic
mRNA expression of MCP-1 and TNF-α showed no differ-
ences after 11 weeks but with a tendency of decreased
MCP-1 in the Lp +GT group (Figure 8C and E). After
22 weeks MCP-1 decreased in the Lp +GT group com-
pared to the Lp group and TNF-α decreased in the Lp +
GT group compared to both the control and the GT group
(p < 0.05) (Figure 8D and F). The hepatic mRNA expres-
sion of PAI-1, TLR4, MyD88 and F4-80 is shown in Add-
itional file 9. A significant difference in the expression of
TLR4 was observed between mice in GT and Lp +GT
groups. Moreover, the spleen weights were decreased innted with green tea and Lactobacillus plantarum. Total cholesterol
c mRNA expression of hydroxy-methyl-glutaryl-CoA reductase (HMGCR,
and 22 weeks respectively. Ctrl = high fat control diet (HFD),
th 4% green tea powder, Lp + GT = HFD supplemented with 4% green
n = 21 at 11 weeks and n = 9–11 at 22 weeks. *p < 0.05, **p < 0.01,
Figure 8 Decreased inflammatory markers in mice fed a combination of green tea and Lactobacillus plantarum. The inflammatory marker
PAI-1 was analyzed in plasma after 11 (A) and 22 (B) weeks using Luminex Technology. Quantitative real-time PCR was used to analyze the liver
mRNA expression of the inflammatory markers monocyte chemoattractant protein 1 (MCP-1, C and D) and tumor necrosing factor α (TNF-α,
E and F) after 11 and 22 weeks of the study. Spleen masses were analyzed as a reflection of inflammatory activity (G and H). Ctrl = high fat
control diet (HFD), Lp = HFD + L. plantarum in the drinking water, GT = HFD supplemented with 4% green tea powder, Lp + GT = HFD
supplemented with 4% green tea powder and L. plantarum in the drinking water. Data are means ± SEM. n = 21 at 11 weeks and n = 9–11 at
22 weeks. *p < 0.05, **p < 0.01, ***p < 0.001.
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11 weeks (p < 0.05) (Figure 8G), and after 22 weeks, mice
in the two GT groups had significantly smaller spleens
compared to the control group (p < 0.001) (Figure 8H).
Multivariate data analysis
A PCA of the metabolic data was performed for the four
groups of mice. The mice fed green tea clustered separ-
ately from the control and Lp groups (data not shown).
An x/y plot showed that most of the variability in the
model was explained by body fat (data not shown).
A PCA was applied on the T-RFLP data of the small
intestine and the caecum, respectively, combined with
the metabolic parameters, in order to reveal differences
and similarities between and within the four groups. The
combined data for the small intestine showed that mice
in the GT and Lp + GT groups displayed more similarity
to each other compared to the control and Lp groups
(data not shown). The combined caecum data indicate
that the mice in the Lp group clustered together while
the mice in the three other groups were more different
from each other (data not shown). A PLS analysis of the
combined data was then performed to reveal any correl-
ation between the T-RFs, i.e. microbiota, and the meta-
bolic parameters.. The obtained PLS loadings bi-plots
showed that the control and the Lp groups were sepa-
rated from the GT and Lp + GT groups (Figure 9A and
B). Variables located closely together are more likely to
have a positive correlation, while variables far away from
each other, either along the first or the second principal
component, are more likely to be negatively correlated.The T-RFs having the most influence on the model are
indicated with their fragment size, and in the small in-
testine a high abundance of T-RFs 118 and 184 corre-
lated positively to the increase of the metabolic markers
while T-RF 271 was negatively correlated (Figure 9A). In
the ceacum, T-RFs 270 and 307 correlated negatively
with all the metabolic markers except SR-B1 expression
and caecum weight while T-RF 568 and 497 correlated
positively with the same data (Figure 9B). The T-RF 568
corresponds to the given strain L. plantarum DSM
15313 and the positive correlation is probably due to the
high abundance of this strain in the Lp group.Discussion
The present study shows that green tea powder (GT)
alone, or in combination with L. plantarum DSM 15313
(Lp), exerts beneficial metabolic effects in C57BL/6J
mice fed an HFD. These results are in agreement with
and an extension of previous studies of metabolic effects
of green tea in rodents. However, in contrast to most
previous studies, in which the green tea extract or the
phenolic constituent epigallocatechin gallate (EGCG)
has been evaluated, we have here studied the effect of
whole tea leaves milled to a powder, which is suggested
to contain higher quantities of polyphenols compared to
a water extract of green tea [45]. Indeed, our analysis of
the green tea powder showed a higher amount of cate-
chins compared to a water extract from the same green
tea powder. The present study additionally shows that
when a tannase active strain of L. plantarum was
Figure 9 PLS plot of the intestinal microbiota and analyzed parameters of individual mice at 22 weeks. Projections to latent structures
(PLS) loadings biplot of the microbiota (T-RFs of the T-RFLP profile) and the physiological parameters (A through Q) of the individual mice in the
small intestine (A) and caecum (B). For the small intestine PC1 explained 25.6% and PC2 15.6% of the variation. For caecum the PC1 explained
26.4% and PC2 16.4% of the variation. Blue open circle represents mice in the control group (Ctrl); orange open triangle for the group
supplemented with L. plantarum DSM 15313 (Lp); green dot for the group supplemented green tea (GT); red triangle for the group
supplemented L. plantarum DSM 15313 and green tea (Lp + GT). Letters denote metabolic parameters, A, body weight; B, body fat content; C,
periovarian white adipose tissue; D, liver weight; E, spleen weight; F, caecum weight; G, liver cholesterol; H, liver TAG; I, plasma ALT; J, plasma
cholesterol; K, plasma insulin; L, plasma glucose; M, plasma leptin; N, PPARα mRNA; O, PPARγ mRNA; P, CD36 mRNA; Q, SR-B1 mRNA. Symbol X
denotes T-RFs. T-RFs having the biggest influence on the model are marked by numbers indicating the fragment size.
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lactobacilli and the bacterial diversity increased signifi-
cantly in the small intestine. It seems likely that the in-
crease in diversity was due to effects exerted by the
given Lactobacillus strain in combination with GT ra-
ther than just the addition of one more species to the
microbiota.
The observed reduction in adiposity after green tea in-
take is in agreement with previous studies, including
studies in HFD-fed C57BL/6J mice. Increased faecal lipid
excretion is likely to be a major factor contributing to
the reduced adiposity. It is known that green tea extracts
possess the ability to inhibit intestinal lipases [46]. In
addition to lipases, green tea catechins have been shown
to inhibit glucose transporters and enzymes involved in
carbohydrate digestion, raising the possibility that also
carbohydrate absorption could be reduced [47,48].
EGCG has previously been shown to slightly increaseenergy content of faeces as a consequence of reduced di-
gestibility [14]. There were indications that components
of the microbiota might interfere with lipid metabolism.
The amount of Akkermansia in the small intestine was
shown to correlate negatively with the total body fat
content, the periovarian fat depots as well as the circu-
lating levels of leptin, suggesting a role for Akkermansia
in reducing fat accumulation. Interestingly, Akkermansia
muciniphila was recently shown to be increased in
prebiotic-treated ob/ob mice which had lower fat mass
compared to control ob/ob mice [49]. In a study of preg-
nant women, the number of Akkermansia and Bifidobac-
terium was higher in women with normal weight gain
compared to those with excessive weight gain [50].
Akkermansia has also been shown to be increased in
normal weight and post-gastric-bypass individuals com-
pared to obese [51]. In the present study, a negative cor-
relation was also detected between the total number of
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to be proven that the correlations point at the cause of
the alterations in lipid metabolism.
In accordance with the reduced adiposity after GT in-
take, GT reduced hepatic lipid content and circulating
levels of ALT suggesting that GT either directly, or indir-
ectly, perhaps via an altered microbiota, ameliorates the
liver damage imposed by the HFD. The involvement of
an altered microbiota is supported by the negative cor-
relation between the amount of Akkermansia and the
hepatic TAG content. Ma et al. demonstrated that the
probiotic mixture of different Lactobacillus and Bifido-
bacterium strains (labelled VSL#3) reduced a HFD
induced hepatic steatosis in C57BL6 mice [11]. On the
other hand Velayudham et al. demonstrated that the
same probiotic mixture did not prevent liver steatosis
but modulated the progression to liver fibrosis [52].
Here, the supplement with one strain of L. plantarum
did not have the capacity to reduce the hepatic TAG ac-
cumulation. SREBP-1c is a key transcription factor in
hepatic lipogenesis and is partly regulated by PPARγ and
LXR [53]. The down-regulation of the mRNA expression
of SREBP-1c, PPARγ and LXR suggests that decreased
hepatic lipogenesis contributes to the reduced hepatic
lipid content observed in the mice fed GT. Also, the
hepatic fatty acid transporter CD36, another lipogenic
target of PPARγ and LXR [53] was shown to be down-
regulated in the GT groups compared to control at
11 weeks, however, the decrease compared to control
was abolished after 22 weeks. In addition, the hepatic
mRNA expression of the lipogenic enzymes ACC and
FAS was reduced and trended towards a diminuition, re-
spectively, in mice fed GT alone compared to control
mice, indicating a decreased de novo lipogenesis in these
mice. Surprisingly, the decreased expression of the lipo-
genic enzymes could not be detected in mice from the
Lp + GT group. The expression of the transcription fac-
tor PPARα was down-regulated in mice in the GT group
compared to control mice, indicating a decreased hep-
atic fatty acid oxidation as well. The mechanisms behind
this finding need further elucidation. It should be
emphasized that this is a large screening of the altera-
tions induced by the dietary supplements and more
detailed analyses, including expression at the protein
level, need to be undertaken.
The choice of the present strain of probiotics is partly
based upon its ability to increase the barrier effect of the
gut-mucosa [54] but mainly on its ability to degrade poly-
phenols as tannins, and produce compounds as substi-
tuted phenyl propionic acids, phenyl valeric acids and
benzoic acid derivates [26]. These compounds are more
easily absorbed than longer molecular chains of phenolics,
and are often also more bioactive [55,56]. They can have
anti-inflammatory effects as well as antimicrobial effects.One hypothesis is that Lp in the large intestine is able to
convert polyphenols in GT to more easily absorbed meta-
bolites with antioxidative effects in organs such as the
liver. Generally, polyphenols possess powerful antimicro-
bial activities [27] which can have growth suppressing
effects on many bacteria but which are better endured by
others.
Feeding mice with Lp alone did not affect inflamma-
tory markers. A reduced spleen weight was observed
already after 11 weeks in the Lp + GT group and Lp +
GT significantly reduced the inflammatory tone at
22 weeks, both systemically, as indicated by reduced cir-
culating PAI-1 and decreased spleen weight [57], as well
as locally in the liver, as shown by decreased mRNA ex-
pression of TNF-α and MCP-1. This, together with the
higher number of Lactobacillus both in caecum and
small intestine in the Lp + GT group support the hypoth-
esis of Lactobacillus converting polyphenols to more ac-
tive anti-inflammatory components. The higher number
of lactobacilli in the Lp group and higher diversity in the
GT group in the ceacum seemed not to affect the in-
flammatory markers at 11 weeks. The effect seen after
22 weeks might partly be explained by an increased
number of bacterial taxa over time in all groups since
the number of T-RFs increased at 22 weeks while no dif-
ference in diversity between the groups was seen in
ceacum.
It has previously been shown that a probiotic-
supplemented diet decreases levels or expression of liver
TNF-α in animal models. Ma et al. [11] found a
decreased expression of TNF-α in the liver of HFD-fed
C57BL/6 mice when the diet was supplemented with the
probiotic VSL#3 mixture. Furthermore, in an acute liver
injury model in rats, TNF-α levels decreased in the liver
when rats had been pre-treated with L. plantarum DSM
15313 before inducing liver injury [58]. Also, green tea
extract alone has been shown to reduce hepatic mRNA
levels of both TNF-α and MCP-1 as well as NFκB bind-
ing activity [59]. Additionally, a negative correlation be-
tween Akkermanisia and plasma PAI-1 was seen,
indicating that Akkermansia may have a beneficial influ-
ence on the inflammatory state. It has been shown in
germ-free mice inoculated with Akkermansia munici-
phila MucT that the colonization altered the mucosal
gene expression towards a profile involved in immune
responses and cell fate, which led to the conclusion that
the tested strain of Akkermansia modulated pathways
involved in establishing homeostasis for basal metabol-
ism and immune tolerance towards commensal bacteria
[60].
Dietary administration of GT reduced plasma cholesterol
as well as hepatic cholesterol content. The supplementa-
tion with Lp alone had a significant cholesterol-lowering
effect in the liver after 22 weeks and additionally the total
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correlated with both liver and plasma cholesterol. An
increased faecal excretion of cholesterol was observed in
the GT groups, indicating that this is at least one of the
mechanisms underlying the cholesterol-lowering effect of
GT administration. EGCG as well as other polyphenols
have previously been shown to inhibit cholesterol ab-
sorption in rodents [61,62]. The underlying mechanisms
are not fully elucidated but green tea catechins have
been suggested to reduce the absorption of cholesterol
from the intestine by reducing the solubility of choles-
terol in mixed micelles [61]. SREBP2, the major regula-
tor in cholesterol biosynthesis, and its downstream
target HMG-CoA reductase, were up-regulated when
GT was combined with Lp. An explanation for the up-
regulated cholesterol biosynthesis might be a response to
the very efficient GT-induced cholesterol excretion in an
attempt of the system to restore cholesterol homeostasis.
This rescue mechanism of cholesterol is further sup-
ported by the upregulation of the hepatic HDL receptor
SR-B1 mRNA in the GT groups.
The lower fasting plasma glucose and insulin, resulting
in a lower HOMA index, as well as the lower levels of
fructosamine, mirroring the blood glucose concentration
over several weeks, indicate a more insulin sensitive
state in the mice fed GT. In contrast, the oral glucose
tolerance test showed deteriorated glucose elimination
despite increased insulin secretion in the GT groups, im-
plying decreased oral glucose tolerance compared to the
control group and the Lp group. The cause for this dis-
crepancy is not known.
A component of the microbiota that seems to be of rele-
vance for several of the metabolic effects studied here is
Akkermansia. Akkermansia muciniphila is a newly
described species which has been shown to be an efficient
mucin degrader found in the intestines of humans and
animals [63] and it has been associated with healthy gut
mucosa [64,65]. However, the amount of Akkermansia in
the small intestine did not differ between the groups indi-
cating that it is not the diet per se but instead the response
of the specific microbiota in an individual that might be of
importance. It is clear from the present results that the
dietary supplements GT and Lp exercise effects on the
composition of the microbiota in both the small intestine
and in caecum as well as on metabolism. However, a key-
question that remains to be answered is whether the
changes in gut-microbiota affect the metabolic markers or
whether the changes in the gut-microbiota result from
metabolic alterations. With the assumption that certain
components of the microbiota exert metabolic effects, it is
clear from the present results that the microbiota of the
individual mice varied widely in spite of the fact that they
are from an inbred strain. Especially the individuals of the
control group differ while the dietary supplements appearto standardize the microbiota to some degree. Surpris-
ingly, the standardization differed between the small intes-
tine and caecum, i.e. green tea made the microbiota of the
individual mice more uniform in the former while Lp did
the same in the latter. The multivariate analysis revealed
that certain, relatively few components of the microbiota
(T-RFs) in both the small intestine and in caecum, had
a considerably higher effect on the correlation model
built for comparing T-RFLP-data with metabolic test-
parameters, some showing positive correlations and some
negative. It was also clear that GT and Lp in some cases
affected the abundance of these bacterial components
differently. One of these critical components (T-RF) could
be identified as Akkermansia. However, the fact that sev-
eral correlations have been found between Akkermansia
and metabolic parameters do not necessarily implicate a
causal role for this taxum but at least reflects that mar-
kers for inflammation and lipid metabolism are linked to
the microbiota, and especially the microbiota of the small
intestine. Mice in the Lp + GT group had higher bacterial
diversity in the small intestine compared to both control
and the GT group. The higher diversity may as such be a
positive health factor or at least a health marker. It was
shown in humans that the bacterial diversity of the gut
microbiota was higher in lean individuals than in obese
ones [66] and that neonates with low diversity at one
week of age had increased risk for developing atopic
eczema at 18 months of age [67]. As expected the number
of T-RFs were smaller in the small intestine compared to
caecum as the sampling were done close to the pylorus.
In humans, the diversity in the jejunum has been shown
to be lower than in the colon [68]. The T-RFLP method
was chosen here even if it has a lower resolution
compared to high through-put sequencing, but it gives
comparable results to pyrotag sequencing regarding
diversity measures [69].
Conclusions
An extensive battery of parameters has been analyzed in
the present study in order to evaluate the effects of two
different dietary supplements alone and in combination
on gut microbiota and metabolism. It seems clear that
some of the metabolic effects described in this study
were accounted for by GT alone, whereas others, notably
the reduced inflammation and up-regulation of genes
regulating cholesterol synthesis, were only significantly
observed with the combination of Lp and GT. We
propose that GT acts as a potent source for dietary poly-
phenols, promoting the growth of a healthy, anti-
inflammatory intestinal microbiota and that addition of
a tannase active strain of L. plantarum results in certain
synbiotic effects. In addition, certain bacterial fractions
of the microbiota correlate positively or negatively with
risk factors for type 2 diabetes. It is of interest to identify
Axling et al. Nutrition & Metabolism 2012, 9:105 Page 16 of 18
http://www.nutritionandmetabolism.com/content/9/1/105the unknown fractions and to clarify if Akkermansia or
some of these unknown correlating fractions are the
actual cause of the observed metabolic alterations.
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